The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Vascular endothelial growth factor (VEGF) and its receptors
Abstract
Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular endothelial cells. Five VEGF isoforms are generated as a result of alternative splicing from a single VEGF gene. These isoforms differ in their molecular mass and in biological properties such as their ability to bind to cell‐surface heparan‐sulfate proteoglycans. The expression of VEGF is potentiated in response to hypoxia, by activated oncogenes, and by a variety of cytokines. VEGF induces endothelial cell proliferation, promotes cell migration, and inhibits apoptosis. In vivo VEGF induces angiogenesis as well as permeabilization of blood vessels, and plays a central role in the regulation of vasculogenesis. Deregulated VEGF expression contributes to the development of solid tumors by promoting tumor angiogenesis and to the etiology of several additional diseases that are characterized by abnormal angiogenesis. Consequently, inhibition of VEGF signaling abrogates the development of a wide variety of tumors. The various VEGF forms bind to two tyrosine‐kinase receptors, VEGFR‐1 ( flt‐1 ) and VEGFR‐2 ( KDR/flk‐1) , which are expressed almost exclusively in endothelial cells. Endothelial cells express in addition the neuropilin‐1 and neuropilin‐2 coreceptors, which bind selectively to the 165 amino acid form of VEGF (VEGF 165 ). This review focuses on recent developments that have widened considerably our understanding of the mechanisms that control VEGF production and VEGF signal transduction and on recent studies that have shed light on the mechanisms by which VEGF regulates angiogenesis.—Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9–22 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Research works printed but not linked: 6
- 10.1210/endo.133.2.7688292 · doi:10.1210/endo.133.2.7688292 · Paper page
- 10.1097/01.iae.0000246884.76018.63 · DOI · Paper page
- 10.1210/endo.137.6.8641174 · doi:10.1210/endo.137.6.8641174 · Paper page
- 10.1006/bbrc.1996.0730 · doi:10.1006/bbrc.1996.0730
- Fournier E., 1997, Receptors for factors of the VEGF family, Bull. Cancer, 84, 397
- 10.1006/bbrc.1995.1492 · doi:10.1006/bbrc.1995.1492
Cited by
Items 201–240 of 240
Dias, S., Shmelkov, S. V., Lam, G., & Rafii, S. (2002) · Blood · doi:10.1182/blood.v99.7.2532 · Cited by 260
Invited review: activity-induced angiogenesis
Egginton, S. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0563-9 · Cited by 259
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Regulation of microvascular permeability by vascular endothelial growth factors*
Bates, D. O., Hillman, N. J., Williams, B., Neal, C. R., & Pocock, T. M. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00066.x · Cited by 258
Ballara, S., Taylor, P. C., Reusch, P., Marm�, D., Feldmann, M., Maini, R. N., & Paleolog, E. M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<2055::aid-art355>3.0.co;2-2 · Cited by 257
Miyazawa-Hoshimoto, S., Takahashi, K., Bujo, H., Hashimoto, N., & Saito, Y. (2003) · Diabetologia · doi:10.1007/s00125-003-1221-6 · Cited by 254
Grunstein, J., Masbad, J. J., Hickey, R., Giordano, F., & Johnson, R. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7282-7291.2000 · Cited by 255
Molecular and functional diversity of vascular endothelial growth factors
Yamazaki, Y., & Morita, T. (2006) · Molecular Diversity · doi:10.1007/s11030-006-9027-3 · Cited by 255
The use of platelet-rich plasma in bone reconstruction therapy
Intini, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.055 · Cited by 255
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders
Carmeliet, P., & Storkebaum, E. (2002) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2001.0290 · Cited by 252
Considerations for successful transplantation of encapsulated pancreatic islets
de Vos, P., Hamel, A. F., & Tatarkiewicz, K. (2002) · Diabetologia · doi:10.1007/s00125-001-0729-x · Cited by 252
Heine, V. M., Zareno, J., Maslam, S., Joëls, M., & Lucassen, P. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03951.x · Cited by 225
Exercise, Vascular Wall and Cardiovascular Diseases: An Update (Part 1)
Leung, F. P., Yung, L. M., Laher, I., Yao, X., Chen, Z. Y., & Huang, Y. (2008) · Sports Medicine · doi:10.2165/00007256-200838120-00005 · Cited by 219
Takeuchi, R., Katagiri, W., Endo, S., & Kobayashi, T. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225472 · Cited by 210
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
“Cell surface receptors to VEGF that were over- expressed in VHL tumors included VEGFR-2 (or Flk-1) and neuropilin-1, an isoform-specific co-receptor for VEGF and receptor for class 3 semaphorins (Neufeld et al. 1999).”
López-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J., & Kerbel, R. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203817 · Cited by 183
Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., & Greenberg, D. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.016 · Cited by 178
“VEGFA acts through two receptor tyrosine kinases, VEGFR1 and VEGFR2, and also interacts with coreceptor neuropilins that may function in ligand presentation, but most known effects of VEGFA have been ascribed to VEGFR2 (Neufeld et al., 1999).”
BackgroundBiomimetic 3D tissue models for advanced high-throughput drug screening
Nam, K.-H., Smith, A. S. T., Lone, S., Kwon, S., & Kim, D.-H. (2015) · SLAS Technology · doi:10.1177/2211068214557813 · Cited by 171
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
Regulation of Vascular Endothelial Growth Factor Synthesis by Nitric Oxide: Facts and Controversies
Dulak, J., & Józkowicz, A. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603321223612 · Cited by 130
Supp, D. M., Supp, A. P., Boyce, S. T., & Bell, S. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00824.x · Cited by 120
In vivo cytokine-associated responses to biomaterials
Schutte, R. J., Xie, L., Klitzman, B., & Reichert, W. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.026 · Cited by 111
“VEGF in the exudate fluid likely promoted the formation of vasculature to support the ingrowth of new tissue into the hollow cage [26].”
BackgroundArsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G., & Giacca, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00034-0 · Cited by 108
Pollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100
Aberrant astrocytes impair vascular reactivity in Huntington disease
Hsiao, H., Chen, Y., Huang, C., Chen, C., Hsu, Y., Chen, H., Chiu, F., Kuo, H., Chang, C., & Chern, Y. (2015) · Annals of Neurology · doi:10.1002/ana.24428 · Cited by 99
Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
Klymenko, Y., Kim, O., & Stack, M. (2017) · Cancers · doi:10.3390/cancers9080104 · Cited by 99
The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation
Melrose, J., Shu, C., Whitelock, J. M., & Lord, M. S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.008 · Cited by 96
Current targeted therapies in the treatment of advanced colorectal cancer: a review
Moriarity, A., O’Sullivan, J., Kennedy, J., Mehigan, B., & McCormick, P. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016646734 · Cited by 87
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production
Lehman, N., Cutrone, R., Raber, A., Perry, R., van't Hof, W., Deans, R., Ting, A. E., & Woda, J. (2012) · Cytotherapy · doi:10.3109/14653249.2012.688945 · Cited by 76
Prasad, S., Sajja, R. K., Park, J. H., Naik, P., Kaisar, M. A., & Cucullo, L. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0014-x · Cited by 77
Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers
Drinkwater, S. L., Burnand, K. G., Ding, R., & Smith, A. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)01053-x · Cited by 57
Song, Y.-S., Joo, H.-W., Park, I.-H., Shen, G.-Y., Lee, Y., Shin, J. H., Kim, H., & Kim, K.-S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179972 · Cited by 53
The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells
HU, J., LI, T., DU, S., CHEN, Y., WANG, S., XIONG, F., & WU, Q. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2195 · Cited by 48
“VEGF is a major cytokine that causes vascular leakage and induces endothelial cell division, proliferation, migration and capillary formation, leading to angiogenesis (4,5).”
BackgroundBosquiazzo, V. L., Ramos, J. G., Varayoud, J., Muñoz-de-Toro, M., & Luque, E. H. (2007) · Reproduction · doi:10.1530/rep-06-0168 · Cited by 35
Stilley, J. A. W., & Sharpe-Timms, K. L. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.094680 · Cited by 29
Feng, Y., Rhodes, P. G., Liu, H., & Bhatt, A. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.024 · Cited by 29
Sun, W., Chen, Y., Wang, Y., Luo, P., Zhang, M., Zhang, H., & Hu, P. (2018) · The Analyst · doi:10.1039/c8an01216d · Cited by 25
Zhu, J.-W., Wu, X.-J., Lu, Z.-F., Luo, D., Cai, S.-Q., & Zheng, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055463 · Cited by 22
Preis, M., Schneiderman, J., Koren, B., Ben-Yosef, Y., Levin-Ashkenazi, D., Shapiro, S., Cohen, T., Blich, M., Israeli-Amit, M., Sarnatzki, Y., et al. (2016) · Gene Therapy · doi:10.1038/gt.2015.104 · Cited by 13
Self-citationRelevance of VEGF and nephrin expression in glomerular diseases
Bertuccio, C. A. (2011) · Journal of Signal Transduction · doi:10.1155/2011/718609 · Cited by 12
“Rodents present the same number of isoforms, although they are one amino acid shorter [50].”
Background
Metadata
- Authors
- NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-01
- Volume
- 13
- Issue
- 1
- Pages
- 9-22
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2141046053
- Cited by
- 3,483
- References
- 180
- FWCI
- 67.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Israel Academy of Sciences and Humanities
- Israel Cancer Research Fund
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.